ACRIVON THERAPEUTICS INC (ACRV)
US0048901096 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ACRV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.57. This target is 135.32% above the current price.
ACRV was analyzed by 16 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACRV.
In the previous month the buy percentage consensus was at a similar level.
ACRV was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-29 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2024-04-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-25 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-04-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-04-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-05 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2024-04-01 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-04-01 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | JMP Securities | Initiate | Market Outperform |
| 2023-11-10 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-10-05 | Maxim Group | Initiate | Buy |
| 2023-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-18 | JonesTrading | Initiate | Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-02 | Oppenheimer | Initiate | Outperform |
| 2023-05-08 | BMO Capital | Initiate | Outperform |
| 2023-05-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-20 | HC Wainwright & Co. | Initiate | Buy |
| 2022-12-12 | Cowen & Co. | Initiate | Outperform |
| 2022-12-12 | Piper Sandler | Initiate | Overweight |
| 2022-12-12 | Jefferies | Initiate | Buy |